Tags: Chemical Compound, Chemical Substance.
CPHPC (R-1-[6-[R-2-carboxy-pyrrolidin-1-yl]-6-oxo-hexanoyl] pyrrolidine-2-carboxylic acid) is a proline-derived small molecule able to strip amyloid P (AP) from deposits by reducing levels of circulating serum amyloid P (SAP). The SAP-amyloid association has also been identified as a possible drug target for anti-amyloid therapy with the recent development and first stage clinical trials of CPHPC for amyloidosis.CPHPC has also been patented for possible treatment of Alzheimer’s disease.
